Karolien Buyl
Brussels, BRU 1090, Belgium
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 19 publications
Human skin stem cell-derived hepatic cells as in vitro drug discovery model for insulin-driven de novo lipogenesis.
Journal: European journal of pharmacology
Published: March 29, 2023
From NAFLD to MAFLD: Aligning Translational In Vitro Research to Clinical Insights.
Journal: Biomedicines
Published: November 29, 2021
Transcriptional Profile of Cytokines, Regulatory Mediators and TLR in Mesenchymal Stromal Cells after Inflammatory Signaling and Cell-Passaging.
Journal: International journal of molecular sciences
Published: May 10, 2021
Flow cytometric quantification of neutral lipids in a human skin stem cell-derived model of NASH.
Journal: MethodsX
Published: June 24, 2020
Human hepatic in vitro models reveal distinct anti-NASH potencies of PPAR agonists.
Journal: Cell biology and toxicology
Published: March 24, 2020
The Impact of Cell-Expansion and Inflammation on The Immune-Biology of Human Adipose Tissue-Derived Mesenchymal Stromal Cells.
Journal: Journal of clinical medicine
Published: January 08, 2020
Anti-NASH Drug Development Hitches a Lift on PPAR Agonism.
Journal: Cells
Published: November 25, 2019
Elafibranor restricts lipogenic and inflammatory responses in a human skin stem cell-derived model of NASH.
Journal: Pharmacological research
Published: December 04, 2018
Comment to 'Letter to the editor: Human-based systems: Mechanistic NASH modelling just around the corner?'
Journal: Pharmacological research
Published: September 27, 2018
Last Updated: 09/26/2026